AI-Powered urine test could revolutionize cervical cancer screening in Low-Income countries

NCT ID NCT06042543

Recruiting now Diagnosis Sponsor: International Agency for Research on Cancer Source: ClinicalTrials.gov ↗

First seen Feb 14, 2026 · Last updated Jun 15, 2026 · Updated 14 times

Summary

This study is testing a new, affordable AI system to screen for cervical cancer in low- and middle-income countries. The AI analyzes urine samples and cervical images to detect high-risk HPV and precancerous changes. About 3,200 unscreened women aged 25-49 in Zimbabwe will take part. The goal is to see if this one-stop approach can accurately identify women who need treatment, helping to eliminate cervical cancer worldwide.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for CERVICAL CANCER are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Show contact details

Study contacts

Contact

Phone: •••-•••-•••• Email: •••••@•••••

Locations

University of Cincinnati
RECRUITING

Cincinnati, Ohio, 45221, United States

Contact Email: •••••@•••••
University of Zimbabwe
RECRUITING

Harare, 0002, Zimbabwe

Contact Email: •••••@•••••

Conditions

Explore the condition pages connected to this study.

CERVICAL CANCER SCREENING SCREENING